Unrelated or haploidentical allogeneic hematopoietic cell transplantation in second complete remission for acute myeloid leukemia—Improved outcomes over time: A European Society for Blood and Marrow Transplantation Acute Leukemia Working Party study

Allogeneic hematopoietic cell transplantation (allo-HCT) is the only cure for acute myeloid leukemia (AML) in second complete remission (CR2) Patients lacking a matched sibling donor (MSD) receive transplants from mismatched unrelated donors .

Four researchers with MIT ties earn 2023 Schmidt Science Fellowships

AI SummaryFour researchers with ties to MIT have been named Schmidt Science Fellows. Lillian Chin, Neil Dalvie, Suong Nguyen, and Yirui Zhang are among the 32 exceptional early-career scientists worldwide chosen to receive the prestigious fellowships. They will receive a stipend of $100,000 a year for up to two years of postdoctoral research in a… Continue reading Four researchers with MIT ties earn 2023 Schmidt Science Fellowships

Researchers map brain cell changes in Alzheimer’s disease

AI SummaryResearchers at the Broad Institute of MIT and Harvard have developed a new method called STARmap PLUS to study the relationship between protein buildup and the death of neurons in Alzheimer’s disease using a mouse model. The technique allows for the simultaneous mapping of gene expression and the spatial distribution of proteins in intact… Continue reading Researchers map brain cell changes in Alzheimer’s disease